BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 28321612)

  • 1. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
    Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
    J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.
    Quartier P; Debré M; De Blic J; de Sauverzac R; Sayegh N; Jabado N; Haddad E; Blanche S; Casanova JL; Smith CI; Le Deist F; de Saint Basile G; Fischer A
    J Pediatr; 1999 May; 134(5):589-96. PubMed ID: 10228295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous immunoglobulin replacement therapy in X-linked agammaglobulinemia].
    Kanegane H; Nomura K; Futatani T; Miyawaki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):337-43. PubMed ID: 16583740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [X-linked agammaglobulinemia: experience in a Portuguese hospital].
    Fernandes A; Guedes M; Vasconcelos J; Neves E; Fernandes S; Marques L
    An Pediatr (Barc); 2015 Mar; 82(3):166-71. PubMed ID: 25443324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
    Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R
    Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.
    Orange JS; Grossman WJ; Navickis RJ; Wilkes MM
    Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study.
    Melamed IR; Borte M; Trawnicek L; Kobayashi AL; Kobayashi RH; Knutsen A; Gupta S; Smits W; Pituch-Noworolska A; Strach M; Pulka G; Ochs HD; Moy JN
    Eur J Pharm Sci; 2018 Jun; 118():80-86. PubMed ID: 29522908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intravenous immunoglobulin replacement therapy in 114 cases of congenital agammaglobulinemia].
    Li YW; Chen H; Zhang Y; An YF; Tang XM; Zhao XD; Zhang ZY
    Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):495-500. PubMed ID: 34102824
    [No Abstract]   [Full Text] [Related]  

  • 9. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
    Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
    Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutropenia associated with X-linked Agammaglobulinemia in an Iranian referral center.
    Aghamohammadi A; Cheraghi T; Rezaei N; Kanegane H; Abdollahzede S; Talaei-Khoei M; Heidari G; Zandieh F; Moin M; Miyawaki T
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):43-7. PubMed ID: 19279358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID).
    Bayrakci B; Ersoy F; Sanal O; Kiliç S; Metin A; Tezcan I
    Turk J Pediatr; 2005; 47(3):239-46. PubMed ID: 16250308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.
    Quinti I; Soresina A; Guerra A; Rondelli R; Spadaro G; Agostini C; Milito C; Trombetta AC; Visentini M; Martini H; Plebani A; Fiorilli M;
    J Clin Immunol; 2011 Jun; 31(3):315-22. PubMed ID: 21365217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Spectrum of Infections in Patients with X-Linked Agammaglobulinemia.
    Paccoud O; Mahlaoui N; Moshous D; Aguilar C; Neven B; Lanternier F; Suarez F; Picard C; Fischer A; Blanche S; Lecuit M; Hermine O; Lortholary O;
    J Clin Immunol; 2021 Aug; 41(6):1266-1271. PubMed ID: 33880703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia.
    Liese JG; Wintergerst U; Tympner KD; Belohradsky BH
    Am J Dis Child; 1992 Mar; 146(3):335-9. PubMed ID: 1543181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
    Sarmiento E; Fernàndez-Yáñez J; Muñoz P; Palomo J; Rodríguez-Molina JJ; Bermejo J; Catalan P; Bouza E; Fernández-Cruz E; Carbone J
    Int Immunopharmacol; 2005 Jan; 5(1):97-101. PubMed ID: 15589466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningoencephalitis in primary antibody deficiency: Our experience from northwest India.
    Jindal AK; Chaudhary H; Tyagi R; Rawat A; Suri D; Patra PK; Arora K; Chawla S; Vyas S; Arora M; Aggarwal R; Basu S; Bansal R; Sachdeva MUS; Gupta A; Pandiarajan V; Sankhyan N; Suthar R; Sahu JK; Singh M; Mani R; Sharma R; Saka R; Imai K; Ohara O; Nonoyama S; Hammarström L; Chan KW; Lau YL; Singh S
    J Neuroimmunol; 2022 Oct; 371():577952. PubMed ID: 36030644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory observation on immunoglobulin replacement therapy switching from an intravenous to a subcutaneous route in a Malaysian X-linked agammaglobulinemia patient.
    Adli A; Wahab AA; Abdul Latiff AH; Ismail IH; Faizah MZ; Boekhren KB; Noh LM
    Med J Malaysia; 2022 Jan; 77(1):95-97. PubMed ID: 35087003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].
    Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M
    Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranoproliferative glomerulonephritis in a patient with X-linked agammaglobulinemia.
    Yoshino A; Honda M; Kanegane H; Obata K; Matsukura H; Sakazume S; Katada Y; Miyawaki T; Ueda Y; Nagai T
    Pediatr Nephrol; 2006 Jan; 21(1):36-8. PubMed ID: 16550363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia.
    Spadaro G; Pecoraro A; De Renzo A; Della Pepa R; Genovese A
    Clin Immunol; 2016 May; 166-167():103-4. PubMed ID: 27063866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.